Samuel Peña-Llopis

发表

Simultaneous isolation of high-quality DNA, RNA, miRNA and proteins from tissues for genomic applications

J. Brugarolas, S. Peña-Llopis, Samuel Peña-Llopis, 2013, Nature Protocols.

A Validated Tumorgraft Model Reveals Activity of Dovitinib Against Renal Cell Carcinoma

D. Bentley, M. Ross, J. Cadeddu, 2012, Science Translational Medicine.

Fish tolerance to organophosphate-induced oxidative stress is dependent on the glutathione metabolism and enhanced by N-acetylcysteine.

S. Peña-Llopis, M. D. Ferrando, J. Peña, 2003, Aquatic toxicology.

Increased recovery of brain acetylcholinesterase activity in dichlorvos-intoxicated European eels Anguilla anguilla by bath treatment with N-acetylcysteine.

Samuel Peña-Llopis, S. Peña-Llopis, M. D. Ferrando, 2003, Diseases of aquatic organisms.

Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: a retrospective analysis with independent validation.

P. Kapur, J. Brugarolas, S. Peña-Llopis, 2013, The Lancet. Oncology.

BAP1 loss defines a new class of renal cell carcinoma

N. Grishin, D. Bentley, M. Ross, 2012, Nature Genetics.

Cooperation and antagonism among cancer genes: the renal cancer paradigm.

J. Brugarolas, Xian-Jin Xie, A. Christie, 2013, Cancer research.

Interplay Between pVHL and mTORC1 Pathways in Clear-Cell Renal Cell Carcinoma

J. Brugarolas, S. Peña-Llopis, T. Yamasaki, 2011, Molecular Cancer Research.

TFEB, a novel mTORC1 effector implicated in lysosome biogenesis, endocytosis and autophagy

J. Brugarolas, S. Peña-Llopis, Samuel Peña-Llopis, 2011, Cell cycle.

A Novel Germline Mutation in BAP1 Predisposes to Familial Clear-Cell Renal Cell Carcinoma

N. Grishin, W. Linehan, L. Schmidt, 2013, Molecular Cancer Research.

Spectrum of diverse genomic alterations define non–clear cell renal carcinoma subtypes

Lisa N Kinch, Nick V Grishin, Na Zhang, 2014, Nature Genetics.

Cullin 5 is a novel candidate tumor suppressor in renal cell carcinoma involved in the maintenance of genome stability

S. Fröhling, S. Peña-Llopis, S. Duensing, 2019, Oncogenesis.

γKlotho is a novel marker and cell survival factor in a subset of triple negative breast cancers

S. Peña-Llopis, E. Martinez, K. F. Tacer, 2015, Oncotarget.

Multistep regulation of TFEB by MTORC1

J. Brugarolas, S. Peña-Llopis, S. Vega-Rubín-de-Celis, 2017, Autophagy.

Macrophage PPARγ inhibits Gpr132 to mediate the anti-tumor effects of rosiglitazone

S. Peña-Llopis, Y. Wan, Peiwen Chen, 2016, eLife.

Jumonji Inhibitors Overcome Radioresistance in Cancer through Changes in H3K4 Methylation at Double-Strand Breaks

S. Peña-Llopis, J. Bayo, E. Martinez, 2018, Cell reports.

Regulation of Beclin 1-Mediated Autophagy by Oncogenic Tyrosine Kinases

S. Peña-Llopis, S. Vega-Rubín-de-Celis, L. Kinch, 2020, International journal of molecular sciences.

The non-apoptotic function of Caspase-8 in negatively regulating the CDK9-mediated Ser2 phosphorylation of RNA polymerase II in cervical cancer

S. Peña-Llopis, F. Rödel, K. Strebhardt, 2022, Cellular and Molecular Life Sciences.

Constitutive soxR Mutations Contribute to Multiple-Antibiotic Resistance in Clinical Escherichia coli Isolates

S. Peña-Llopis, B. Demple, Anastasia Koutsolioutsou, 2005, Antimicrobial Agents and Chemotherapy.

TFEB-mediated lysosomal biogenesis and lysosomal drug sequestration confer resistance to MEK inhibition in pancreatic cancer

S. Peña-Llopis, S. Vega-Rubín-de-Celis, S. Hahn, 2020, Cell Death Discovery.

Nullifying the CDKN2AB Locus Promotes Mutant K-ras Lung Tumorigenesis

L. Girard, S. Peña-Llopis, P. Scaglioni, 2014, Molecular Cancer Research.

Regulation of TFEB and V-ATPases by mTORC1

D. Corey, L. Zou, J. Brugarolas, 2011, The EMBO journal.

Prospective evaluation of plasma levels of ANGPT2, TuM2PK, and VEGF in patients with renal cell carcinoma

J. Brugarolas, S. Peña-Llopis, Y. Lotan, 2015, BMC Urology.

A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth

S. Peña-Llopis, A. Simeonov, Junjie Xu, 2013, Nature Communications.

A small molecule modulates Jumonji histone demethylase activity and selectively inhibits cancer growth

S. Peña-Llopis, A. Simeonov, R. Brekken, 2013, Nature Communications.

Fibroblast Growth Factor Receptor-Dependent and -Independent Paracrine Signaling by Sunitinib-Resistant Renal Cell Carcinoma

J. Brugarolas, S. Peña-Llopis, Andrea Pavía-Jiménez, 2016, Molecular and Cellular Biology.

An integrative somatic mutation analysis to identify pathways linked with survival outcomes across 19 cancer types

Sunho Park, Min-Su Kim, Beibei Chen, 2015, bioRxiv.

Deregulation of mTORC 1 in ccRCC 1 Interplay between pVHL and mTORC 1 pathways in clear-cell renal cell carcinoma

J. Brugarolas, S. Peña-Llopis, T. Yamasaki, 2011 .

Signaling and Regulation Interplay Between pVHL and mTORC 1 Pathways in Clear-Cell Renal Cell Carcinoma

J. Brugarolas, S. Peña-Llopis, T. Yamasaki, 2011 .

Deregulation of mTORC1 in ccRCC

S. Peña-Llopis, T. Yamasaki, S. Sivanand, 2011 .

Impaired glutathione redox status is associated with decreased survival in two organophosphate-poisoned marine bivalves.

S. Peña-Llopis, M. D. Ferrando, J. Peña, 2002, Chemosphere.

Chemical inhibition of RNA viruses reveals REDD1 as a host defense factor.

C. Forst, J. Brugarolas, S. Peña-Llopis, 2011, Nature chemical biology.